8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study)

Anne Boerekamps, Thomas Vanwolleghem, M van der Valk, GE van den Berk, M van Kasteren, D Posthouwer, ASM Dofferhoff, B van Hoek, D Ramsoekh, J Koopsen, J Schinkel, E Florence, JE Arends, Bart Rijnders

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)554-557
Number of pages4
JournalJournal of Hepatology
Volume70
Issue number3
DOIs
Publication statusPublished - 2019

Research programs

  • EMC MM-04-20-02-A

Cite this